https://www.selleckchem.com/Androgen-Receptor.html
To determine efficacy of peficitinib in reducing joint damage, and predictive factors affecting treatment response in Japanese patients with rheumatoid arthritis (RA). This post hoc analysis used data from a placebo-controlled, phase 3 trial (RAJ4) of peficitinib in patients with RA and inadequate response to methotrexate. Erosion and joint space narrowing (JSN) was assessed at baseline and at Week 28/early termination (ET) of treatment using the van der Heijde-modified Sharp method. Univariate logistic regression analysis of change fr
Aimer
Commentaire
Partagez
